| Jan 2024 | Jan 2023 | Apr 2022 | Jan 2022 | Jan 2021 | ||
|---|---|---|---|---|---|---|
| Total Revenue | ||||||
| Cost of Revenue | ||||||
| Gross Profit | ||||||
| Gross Profit Margin (%) | ||||||
| R&D Expense | ||||||
| SG&A Expense | ||||||
| Total Operating Expenses | ||||||
| Operating Income or Loss | ||||||
| Operating Margin (%) | ||||||
| Interest Expense | ||||||
| Total Other Income/Expenses | ||||||
| Income Before Tax | ||||||
| Income Tax Expense | ||||||
| Income from Continuing Ops. | ||||||
| Net Income | ||||||
| Net Profit Margin (%) | ||||||
| Net Income Available to Common Shareholders | ||||||
| Basic EPS | ||||||
| Diluted EPS | ||||||
| Basic Average Shares | ||||||
| Diluted Average Shares |
| Oct 2024 | Jul 2024 | Apr 2024 | Jan 2024 | Oct 2023 | Jul 2023 | Apr 2023 | Jan 2023 | Oct 2022 | Jul 2022 | Apr 2022 | Jan 2022 | Oct 2021 | Jul 2021 | Apr 2021 | Jan 2021 | Oct 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | ||||||||||||||||||
| Cost of Revenue | ||||||||||||||||||
| Gross Profit | ||||||||||||||||||
| Gross Profit Margin (%) | ||||||||||||||||||
| R&D Expense | ||||||||||||||||||
| SG&A Expense | ||||||||||||||||||
| Total Operating Expenses | ||||||||||||||||||
| Operating Income or Loss | ||||||||||||||||||
| Operating Margin (%) | ||||||||||||||||||
| Interest Expense | ||||||||||||||||||
| Total Other Income/Expenses | ||||||||||||||||||
| Income Before Tax | ||||||||||||||||||
| Income Tax Expense | ||||||||||||||||||
| Income from Continuing Ops. | ||||||||||||||||||
| Net Income | ||||||||||||||||||
| Net Profit Margin (%) | ||||||||||||||||||
| Net Income Available to Common Shareholders | ||||||||||||||||||
| Basic EPS | ||||||||||||||||||
| Diluted EPS | ||||||||||||||||||
| Basic Average Shares | ||||||||||||||||||
| Diluted Average Shares |
| Jan 2024 | Jan 2023 | Apr 2022 | Jan 2022 | Jan 2021 | ||
|---|---|---|---|---|---|---|
| Current Assets | ||||||
| Cash & Cash Equivalents | ||||||
| Marketable Securities | ||||||
| Receivables | ||||||
| Inventories | ||||||
| Other Current Assets | ||||||
| Total Current Assets | ||||||
| Non-Current Assets | ||||||
| Marketable Securities | ||||||
| PPE Net | ||||||
| Intangibles inc. Goodwill | ||||||
| Other Non-Current Assets | ||||||
| Total Non-Current Assets | ||||||
| Total Assets | ||||||
| Current Liabilities | ||||||
| Accounts Payable | ||||||
| Deferred Revenues | ||||||
| Debt, Current | ||||||
| Accrued Liabilities | ||||||
| Other Current Liabilities | ||||||
| Total Current Liabilities | ||||||
| Non-Current Liabilities | ||||||
| Deferred Revenues | ||||||
| Debt, Non-Current | ||||||
| Other Non-Current Liabilities | ||||||
| Total Non-Current Liabilities | ||||||
| Total Liabilities | ||||||
| Shareholders' Equity | ||||||
| Common Stock | ||||||
| Additional Paid-In Capital | ||||||
| Retained Earnings | ||||||
| Other Shareholders' Equity | ||||||
| Total Shareholders' Equity | ||||||
| Total Liabilities & Shareholders' Equity |
| Oct 2024 | Jul 2024 | Apr 2024 | Jan 2024 | Oct 2023 | Jul 2023 | Apr 2023 | Jan 2023 | Oct 2022 | Jul 2022 | Apr 2022 | Jan 2022 | Oct 2021 | Jul 2021 | Apr 2021 | Jan 2021 | Oct 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||||||||||
| Cash & Cash Equivalents | ||||||||||||||||||
| Marketable Securities | ||||||||||||||||||
| Receivables | ||||||||||||||||||
| Inventories | ||||||||||||||||||
| Other Current Assets | ||||||||||||||||||
| Total Current Assets | ||||||||||||||||||
| Non-Current Assets | ||||||||||||||||||
| Marketable Securities | ||||||||||||||||||
| PPE Net | ||||||||||||||||||
| Intangibles inc. Goodwill | ||||||||||||||||||
| Other Non-Current Assets | ||||||||||||||||||
| Total Non-Current Assets | ||||||||||||||||||
| Total Assets | ||||||||||||||||||
| Current Liabilities | ||||||||||||||||||
| Accounts Payable | ||||||||||||||||||
| Deferred Revenues | ||||||||||||||||||
| Debt, Current | ||||||||||||||||||
| Accrued Liabilities | ||||||||||||||||||
| Other Current Liabilities | ||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||
| Non-Current Liabilities | ||||||||||||||||||
| Deferred Revenues | ||||||||||||||||||
| Debt, Non-Current | ||||||||||||||||||
| Other Non-Current Liabilities | ||||||||||||||||||
| Total Non-Current Liabilities | ||||||||||||||||||
| Total Liabilities | ||||||||||||||||||
| Shareholders' Equity | ||||||||||||||||||
| Common Stock | ||||||||||||||||||
| Additional Paid-In Capital | ||||||||||||||||||
| Retained Earnings | ||||||||||||||||||
| Other Shareholders' Equity | ||||||||||||||||||
| Total Shareholders' Equity | ||||||||||||||||||
| Total Liabilities & Shareholders' Equity |
| Jan 2024 | Jan 2023 | Apr 2022 | Jan 2022 | Jan 2021 | ||
|---|---|---|---|---|---|---|
| Cash Flows from Operating Activities | ||||||
| Net Income | ||||||
| Depreciation & Amortization | ||||||
| Deferred Income Taxes | ||||||
| Stock Based Compensation | ||||||
| Accounts Receivable | ||||||
| Inventory | ||||||
| Accounts Payable | ||||||
| Deferred Revenue | ||||||
| Other Non-Cash | ||||||
| Operating Cash Flow | ||||||
| Cash Flows from Investing Activities | ||||||
| PPE Investments | ||||||
| Net Acquisitions | ||||||
| Purchase of Investments | ||||||
| Sale of Investments | ||||||
| Other Investing Activity | ||||||
| Investing Cash Flow | ||||||
| Cash Flows from Financing Activities | ||||||
| Debt Issued | ||||||
| Proceeds from Debt Repayment | ||||||
| Debt Repayment | ||||||
| Proceeds from Sale of Equity | ||||||
| Equity Repurchased | ||||||
| Dividend Paid | ||||||
| Other Financing Activity | ||||||
| Financing Cash Flow | ||||||
| Cash Position | ||||||
| Beginning Cash Position | ||||||
| End Cash Position | ||||||
| Change in Cash | ||||||
| Free Cash Flow | ||||||
| Operating Cash Flow | ||||||
| Capital Expenditure | ||||||
| Free Cash Flow |
| Oct 2024 | Jul 2024 | Apr 2024 | Jan 2024 | Oct 2023 | Jul 2023 | Apr 2023 | Jan 2023 | Oct 2022 | Jul 2022 | Apr 2022 | Jan 2022 | Oct 2021 | Jul 2021 | Apr 2021 | Jan 2021 | Oct 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flows from Operating Activities | ||||||||||||||||||
| Net Income | ||||||||||||||||||
| Depreciation & Amortization | ||||||||||||||||||
| Deferred Income Taxes | ||||||||||||||||||
| Stock Based Compensation | ||||||||||||||||||
| Accounts Receivable | ||||||||||||||||||
| Inventory | ||||||||||||||||||
| Accounts Payable | ||||||||||||||||||
| Deferred Revenue | ||||||||||||||||||
| Other Non-Cash | ||||||||||||||||||
| Operating Cash Flow | ||||||||||||||||||
| Cash Flows from Investing Activities | ||||||||||||||||||
| PPE Investments | ||||||||||||||||||
| Net Acquisitions | ||||||||||||||||||
| Purchase of Investments | ||||||||||||||||||
| Sale of Investments | ||||||||||||||||||
| Other Investing Activity | ||||||||||||||||||
| Investing Cash Flow | ||||||||||||||||||
| Cash Flows from Financing Activities | ||||||||||||||||||
| Debt Issued | ||||||||||||||||||
| Proceeds from Debt Repayment | ||||||||||||||||||
| Debt Repayment | ||||||||||||||||||
| Proceeds from Sale of Equity | ||||||||||||||||||
| Equity Repurchased | ||||||||||||||||||
| Dividend Paid | ||||||||||||||||||
| Other Financing Activity | ||||||||||||||||||
| Financing Cash Flow | ||||||||||||||||||
| Cash Position | ||||||||||||||||||
| Beginning Cash Position | ||||||||||||||||||
| End Cash Position | ||||||||||||||||||
| Change in Cash | ||||||||||||||||||
| Free Cash Flow | ||||||||||||||||||
| Operating Cash Flow | ||||||||||||||||||
| Capital Expenditure | ||||||||||||||||||
| Free Cash Flow |
